Praxis Precision Medicines, Inc. (PRAX)
251.29
-8.57
(-3.30%)
USD |
NASDAQ |
Oct 12, 16:00
251.29
0.00 (0.00%)
After-Hours: 17:50
Praxis Precision Medicines Cash from Investing (Quarterly) : 10.98M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.98M |
| March 31, 2026 | -344.28M |
| December 31, 2025 | -328.39M |
| September 30, 2025 | 50.41M |
| June 30, 2025 | 17.89M |
| March 31, 2025 | -51.06M |
| December 31, 2024 | -10.92M |
| September 30, 2024 | 49.57M |
| June 30, 2024 | -195.92M |
| March 31, 2024 | -91.22M |
| December 31, 2023 | -0.05M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 5.00M |
| March 31, 2023 | 34.00M |
| Date | Value |
|---|---|
| December 31, 2022 | 22.59M |
| September 30, 2022 | 47.96M |
| June 30, 2022 | 34.89M |
| March 31, 2022 | -8.55M |
| December 31, 2021 | 10.17M |
| September 30, 2021 | 13.55M |
| June 30, 2021 | -24.23M |
| March 31, 2021 | -140.01M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -5.102B |
| Insmed, Inc. | 24.51M |
| Vertex Pharmaceuticals, Inc. | -45.80M |
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Xencor, Inc. | 85.12M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -77.19M |
| Cash from Financing (Quarterly) | 4.224M |
| Free Cash Flow | -306.32M |
| Free Cash Flow Per Share (Quarterly) | -2.685 |
| Free Cash Flow to Equity (Quarterly) | -77.86M |
| Free Cash Flow to Firm (Quarterly) | -78.21M |
| Free Cash Flow Yield | -4.63% |